These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7730713)

  • 1. Patient treatment compliance in leprosy; an unjustifiably critical review.
    Ellard GA
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):117-21. PubMed ID: 7730713
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient treatment compliance in leprosy; a critical review.
    Vadher A; Lalljee M
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):587-607. PubMed ID: 1369685
    [No Abstract]   [Full Text] [Related]  

  • 3. A-MDT, a slowly ticking time bomb?
    Pandey A
    Lepr Rev; 2007 Jun; 78(2):165-6. PubMed ID: 17824490
    [No Abstract]   [Full Text] [Related]  

  • 4. How can adherence with multi-drug therapy in leprosy be improved?
    Williams MC
    Lepr Rev; 2005 Jun; 76(2):160-1. PubMed ID: 16038249
    [No Abstract]   [Full Text] [Related]  

  • 5. Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.
    Honrado ER; Tallo V; Balis AC; Chan GP; Cho SN
    Dermatol Clin; 2008 Apr; 26(2):221-9, vi. PubMed ID: 18346553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of long absentees among multibacillary leprosy patients admitted to a controlled clinical study.
    Jaggarajamma K; Thomas A; Nagarajan M
    Indian J Lepr; 2000; 72(4):469-75. PubMed ID: 11212481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of multidrug therapy blister-calendar packs in an urban leprosy control programme in Bombay.
    Revankar CR; Dhamale CB; Ganapati R
    Lepr Rev; 1991 Sep; 62(3):336. PubMed ID: 1795592
    [No Abstract]   [Full Text] [Related]  

  • 8. A study on non-adherence to MDT among leprosy patients.
    Rao PS
    Indian J Lepr; 2008; 80(2):149-54. PubMed ID: 19425509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leprosy disease in Nepal : knowledge and non-compliance of patients.
    Chalise SC
    JNMA J Nepal Med Assoc; 2005; 44(158):39-43. PubMed ID: 16554869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How we have ensured the proper taking of medication in a multi-drug therapy program in Vietnam].
    Duê LK
    Acta Leprol; 1986; 4(4):491-3. PubMed ID: 3296621
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventive treatment of leprosy: needs, opportunities, and feasibility.
    Smith WC; Smith CM
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S38-44. PubMed ID: 10700936
    [No Abstract]   [Full Text] [Related]  

  • 12. From vertical to integration for elimination: recent changes in the National Leprosy Eradication Programme in India.
    Thakar HG; Kumar A
    Indian J Public Health; 2003; 47(4):191-207. PubMed ID: 15125562
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needed research in chemotherapy of leprosy related to the individual patient.
    Jacobson RR
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S16-20. PubMed ID: 9030119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow charts for use in leprosy control programmes.
    Nickless SJ
    Lepr Rev; 1986 Jun; 57(2):169-76. PubMed ID: 3747707
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current treatment of leprosy].
    Gac Med Mex; 1990; 126(3):235-6. PubMed ID: 2094624
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of relapsed leprosy.
    Jacobson RR
    Indian J Lepr; 1995; 67(1):99-102. PubMed ID: 7622935
    [No Abstract]   [Full Text] [Related]  

  • 18. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
    Kumar RB; Singhasivanon P; Sherchand JB; Mahaisavariya P; Kaewkungwal J; Peerapakorn S; Mahotarn K
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of leprosy].
    López-Antuñano FJ
    Salud Publica Mex; 1998; 40(1):66-75. PubMed ID: 9580503
    [No Abstract]   [Full Text] [Related]  

  • 20. Leprosy and international adoption: a case report and review of diagnostic and treatment dilemmas.
    King K; Browning JC; Metry DW; Prestigiacomo J; Scollard D; Schutze GE; Stryjewska B; Schwarzwald H
    Pediatr Infect Dis J; 2009 Apr; 28(4):322-5. PubMed ID: 19238115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.